956123-06-1

Basic information

• Product Name: 2-[4-((R)-2-Amino-butylamino)-5-fluoro-pyrimidin-2-yl]-4-(1-methyl-1H-pyrazol-4-yl)-phenol
• Synonyms: 2-[4-((R)-2-Amino-butylamino)-5-fluoro-pyrimidin-2-yl]-4-(1-methyl-1H-pyrazol-4-yl)-phenol
• CAS NO: 956123-06-1
• Molecular Weight: 356.403
• Mol File: 956123-06-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[4-((R)-2-Amino-butylamino)-5-fluoro-pyrimidin-2-yl]-4-(1-methyl-1H-pyrazol-4-yl)-phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[4-((R)-2-Amino-butylamino)-5-fluoro-pyrimidin-2-yl]-4-(1-methyl-1H-pyrazol-4-yl)-phenol(956123-06-1)
• EPA Substance Registry System: 2-[4-((R)-2-Amino-butylamino)-5-fluoro-pyrimidin-2-yl]-4-(1-methyl-1H-pyrazol-4-yl)-phenol(956123-06-1)

Safety Data

• Hazardous Substances Data: 956123-06-1(Hazardous Substances Data)

Upstream product

• 956125-27-2 [(R)-1-({5-Fluoro-2-[2-methoxy-5-(1-methyl-1H-pyrazol-4-yl)-phenyl]-pyrimidin-4-ylamino}-methyl)-propyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain amino-ethyl-amino-aryl (AEAA) compounds which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.